p53-independent dephosphorylation and cleavage of retinoblastoma protein during tamoxifen-induced apoptosis in human breast carcinoma cells

Cancer Letters

Volumn 130, Issue 1-2, 1998, Pages 103-113

  Fattman, Cheryl L ^a   An, Bing ^a   Sussman, Lachelle ^a   Dou, Q Ping ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Breast cancer; p21; p53; RB; Tamoxifen

Indexed keywords

ANTIESTROGEN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN P53; RETINOBLASTOMA PROTEIN; TAMOXIFEN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

APOPTOSIS; ARTICLE; BREAST CARCINOMA; DEPHOSPHORYLATION; HUMAN; HUMAN CELL; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN DEGRADATION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BREAST NEOPLASMS; DNA FRAGMENTATION; DNA, NEOPLASM; FEMALE; HUMANS; NEOPLASM PROTEINS; PHOSPHORYLATION; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; RETINOBLASTOMA PROTEIN; TAMOXIFEN; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0032516708     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00121-9     Document Type: Article

References (41)

1. Chen H.M., Tritton T.R., Kenny N., Absher M., Chiu J.F. Tamoxifen induces TGF β1 activity and apoptosis of human MCF-7 breast cancer cells in vitro. J. Cell. Biochem. 61:1996;9-17.
2. Osbourne C.K., Boldt D.H., Clark G.M., Trent J.M. Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase. Cancer Res. 43:1983;3583-3585.
3. Perry R.R., Kang Y., Greaves B. Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase. Cancer Res. 43:1983;3583-3585.
4. Kellen J.A. Genomic effects of tamoxifen. Anticancer Res. 16:1996;3537-3541.
5. Benson J.R., Baum M. Modulation of transforming growth factor beta expression and induction of apoptosis by tamoxifen in ER positive and ER negative breast cancer cells. Br. J. Cancer. 74:1996;993-994.
6. Perry R.R., Kang Y., Greaves B.R. Relationship between tamoxifen-induced transforming growth factor β1 expression, cytostasis and apoptosis in human breast cancer cells. Br. J. Cancer. 72:1995;1441-1446.
7. Hartwell L.H., Kastan M.B. Cell cycle control and cancer. Science. 266:1994;1821-1828.
8. Slebos R.J.C., Lee M.H., Plunkett B.S., Kessis T.D., Williams B.O., Jacks T., Hedrick L., Kastan M.B., Cho K.R. p53-dependent G1 arrest involves pRB-related protein and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc. Natl. Acad. Sci. USA. 91:1994;5320-5324.
9. Demers G.W., Foster S.A., Halbert C.L., Galloway D.A. Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7. Proc. Natl. Acad. Sci. USA. 91:1994;4382-4386.
10. Strasser A., Harris A.W., Jacks T., Cory S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanism inhibitable by bcl-2. Cell. 79:1990;417-422.
11. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell. 81:1995;323-330.
12. Buchkovich K., Duffy L.A., Harlow E.A. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell. 58:1989;1097-1105.
13. Chen P.L., Scully P., Shew J.Y., Wang J.Y.J., Lee W.H. Phosphorylation of the retinoblastoma gene product is mediated during the cell cycle and cellular differentiation. Cell. 58:1989;1193-1198.
14. DeCaprio J.A., Ludlow J.W., Lynch D., Furukawa Y., Griffin J., Piwnica-Worms H., Huang C.M., Livingston D.M. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell. 58:1989;1085-1095.
15. Mihara K., Cao X.R., Yen A., Chandler S., Driscoll B., Murphee A.L., T'Ang A., Fung Y.K. Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science. 246:1989;1300-1303.
16. Akiyama T., Ohuchi T., Sumida S., Matsumoto K., Toyoshima K. Phosphorylation of the retinoblastoma protein by cdk2. Proc. Natl. Acad. Sci. USA. 89:1992;7900-7904.
17. Hinds P.W., Mittnacht S., Dulic V., Arnold A., Reed S.I., Weinberg R.A. Regulation of the retinoblastoma protein functions by ectopic expression of human cycling. Cell. 70:1992;993-1006.
18. Dou Q.P., Levin A.H., Zhao S., Pardee A.B. Cyclin E and cyclin A as candidates for the restriction point protein. Cancer Res. 53:1993;1493-1497.
19. An B., Dou Q.P. Cleavage of retinoblastoma protein during apoptosis: an interleukin-1β-converting enzyme-like protease as candidate. Cancer Res. 56:1996;438-442.
20. Dou Q.P., An B., Will P.L. Induction of a retinoblastoma phosphatase activity by anticancer drugs accompanies p53-independent G1 arrest and apoptosis. Proc. Natl. Acad. Sci. USA. 92:1995;9019-9023.
21. Morana S.J., Wolf C.M., Li J., Reynolds J.E., Brown M.K., Eastman A. The involvement of protein phosphatases in the activation of ICE/CED-3 protease, intracellular acidification, DNA digestion and apoptosis. J. Biol. Chem. 271:1996;18263-18271.
22. Martin S.J., Green D.R. Protease activation during apoptosis: death by a thousand cuts? Cell. 82:1995;349-352.
23. Lazebnick Y.A., Cole S., Cooke C.A., Nelson W.G., Earnshaw W.C. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature. 371:1994;346-347.
24. Fattman C.L., An B., Dou Q.P. Characterization of interior cleavage of retinoblastoma protein in apoptosis. J. Cell. Biochem. 67:1997;399-408.
25. Chen W.D., Otterson G.A., Lipkowitz S., Khleif S.N., Coxon A.B., Kaye F.J. Apoptosis is associated with cleavage of a 5 kDa fragment form RB which mimics dephosphorylation and modulates E2F binding. Oncogene. 14:1997;1243-1248.
26. Janicke R.U., Walder P.A., Lin X.Y., Porter A.G. Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis. EMBO J. 15:1996;6969-6978.
27. Tan X., Martin S.J., Green D.R., Wang Y.J. Degradation of retinoblastoma protein in tumor necrosis factor- and CD95-induced cell death. J. Biol. Chem. 272:1997;9613-9616.
28. White E. Life, death and the pursuit of apoptosis. Genes Dev. 10:1996;1-15.
29. Nicoletti I., Migliorati G., Pagliacci M.C., Grignani F., Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods. 139:1991;271-279.
30. Runnebaum I.B., Nagarajan M., Bowman M., Soto D., Sukumar S. Mutations in p53 as potential molecular markers for human breast cancer. Proc. Natl. Acad. Sci. USA. 88:1991;10657-10661.
31. Lippman M.E., Bolan G., Huff K.K. The effects of estrogens and antiestrogens on hormone responsive human breast cancer in long term tissue cultures. Cancer Res. 36:1976;4595-4601.
32. Clemmons D.R., Camacho-Hubner C., Coronado E., Osbourne C.K. Insulin-like growth factor binding protein secretion by breast carcinoma cell lines: correlation with estrogen receptor status. Endocrinology. 127:1990;2679-2686.
33. Wyllie A.H., Kerr J.F.R., Currie A.R. Molecular regulation of apoptosis: genetic controls on cell death. Int. Rev. Cytol. 68:1980;251-306.
34. Poon R.Y.C., Jiang W., Toyoshima H., Hunter T. Cyclin-dependent kinases are inactivated by a combination of p21 and Thr-14/Tyr15 phosphorylation after UV-induced DNA damage. J. Biol. Chem. 271:1996;13283-13291.
35. Roberts A.B., Anzano M.A., Wakefield L.M., Roche N.S., Stern D.F., Sporn M.B. Type β transforming growth factor: a bifunctional regulator of cellular growth. Proc. Natl. Acad. Sci. USA. 88:1985;119-123.
36. Arteaga C.L., Tandon A.K., Von Hoff D.D., Osbourne C.K. Transforming growth factor β: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells. Cancer Res. 48:1988;3899-3904.
37. Evan G.L., Wyllie A.H., Gilbert C.S., Littlewood T.D., Land H., Brooks M., Walters C.M., Penn L.Z., Hancock D.C. Induction of apoptosis in fibroblasts by c-myc protein. Cell. 69:1992;119-128.
38. Kang Y., Cortina R., Perry R.R. Role of tamoxifen-induced apoptosis in estrogen-independent breast cancer cells. J. Natl. Cancer Inst. 88:1996;279-284.
39. Elledge R.M., Green S., Howes L., Clark G.M., Berardo M., Allred D.C., Pugh R., Ciocca D., Ravdin P., O'Sullivan J., Rivkin S., Martino S., Osbourne C.K. bcl-2, p53, and response to tamoxifen in estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group study. J. Clin. Oncol. 15:1997;1916-1922.
40. Saltis J. TGF-β: receptors and cell cycle arrest. Mol. Cell. Endocrinol. 116:1996;227-232.
41. Robbins P.D., Shao Z., Adnane J., Siegert J.L. Transcriptional regulation by the retinoblastoma tumor suppressor protein. Mol. Cells. 5:1995;529-538.